Safety and feasibility of intrathecal pembrolizumab infusion in refractory triple negative breast cancer with leptomeningeal disease: A case report

Shannon P.Fortin Ensign, Eric Yancey, Karen S. Anderson, Maciej M. Mrugala

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and feasibility of intrathecal pembrolizumab infusion in refractory triple negative breast cancer with leptomeningeal disease: A case report'. Together they form a unique fingerprint.

Medicine & Life Sciences